XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jul. 01, 2023
Jul. 02, 2022
Cash flows from operating activities:    
Consolidated net income $ 513,116 $ 737,491
Adjustments to reconcile consolidated net income to net cash provided by (used for) operations:    
Depreciation and amortization 92,943 95,557
Amortization of stock-based compensation 28,349 31,236
Equity in earnings of affiliated companies (2,981) (3,008)
Deferred income taxes (33,399) (6,684)
(Gain) loss on investments, net (10,808) 7,733
Other 2,986 2,366
Change in assets and liabilities:    
Accounts receivable, net 1,324,772 (34,207)
Inventories (141,373) (755,892)
Accounts payable (1,513,259) (315,459)
Accrued expenses (215,583) 60,123
Other assets and liabilities 52,237 (102,086)
Net cash provided by (used for) operating activities 97,000 (282,830)
Cash flows from investing activities:    
Acquisition of property, plant, and equipment (37,105) (36,244)
Proceeds from collections of notes receivable 237 20,542
Proceeds from settlement of net investment hedge 10,725 0
Net cash used for investing activities (26,143) (15,702)
Cash flows from financing activities:    
Change in short-term and other borrowings 198,339 296,022
(Repayments of) proceeds from long-term bank borrowings, net (9,426) 910,000
Net proceeds from note offering 496,268 0
Redemption of notes (300,000) (350,000)
Proceeds from exercise of stock options 16,381 15,672
Repurchases of common stock (516,217) (483,963)
Settlement of forward-starting interest rate swap 56,711 0
Other (142) (137)
Net cash (used for) provided by financing activities (58,086) 387,594
Effect of exchange rate changes on cash 50,696 (85,660)
Net increase in cash and cash equivalents 63,467 3,402
Cash and cash equivalents at beginning of period 176,915 222,194
Cash and cash equivalents at end of period $ 240,382 $ 225,596